AI-generated summary
This review and meta-analysis of 33 relevant articles reports that low-level laser therapy reduced the risk, duration and severity of cancer therapy-induced oral mucositis, with similar results for red and infrared wavelengths. The authors describe no adverse side effects and rate the evidence as moderate-to-strong, but their dosing recommendations are their own interpretation rather than a tested protocol.
- Studies included
- 33
- Who or what was studied
- Patients receiving cancer therapy who develop oral mucositis
- Wavelengths
- 630, 670, 780, 830 nm
- Limits stated in the abstract
- The abstract does not describe the quality of the included studies or the degree of heterogeneity among them, so the strength of the pooled estimates cannot be fully judged.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630-670 nm, 780-830 nm
- Energy density (fluence)
- 3 J/cm2, 4 J/cm2
- Power
- 100 mW
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Oral mucositis, Meta-analysis, Laser, Confidence interval, Systematic review, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.